Get the Stockscreener App
60.27
2.71%
1.59
After Hours:
60.14
-0.13
-0.22%
Hims Hers Health Inc stock is traded at $60.27, with a volume of 35.52M.
It is up +2.71% in the last 24 hours and up +21.98% over the past month.
Hims & Hers Health Inc is a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals, enabling them to access high-quality medical care for numerous conditions related to mental health, sexual health, dermatology, haircare and more.
See More
Previous Close:
$58.68
Open:
$57.6
24h Volume:
35.52M
Relative Volume:
0.78
Market Cap:
$12.99B
Revenue:
$1.78B
Net Income/Loss:
$164.40M
P/E Ratio:
87.35
EPS:
0.69
Net Cash Flow:
$236.51M
1W Performance:
+20.52%
1M Performance:
+21.98%
6M Performance:
+89.17%
1Y Performance:
+177.61%
1-Day Range:
$56.10
$60.96
1-Week Range:
$54.30
$60.96
52-Week Range:
$13.47
$72.98
Hims Hers Health Inc Stock (HIMS) Company Profile
Name
Hims Hers Health Inc
Sector
Industry
Phone
415-851-0195
Address
2269 CHESTNUT ST, SAN FRANCISCO
Compare HIMS with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HIMS
Hims Hers Health Inc
|
60.27 | 13.13B | 1.78B | 164.40M | 236.51M | 0.69 |
|
PG
Procter Gamble Co
|
156.61 | 368.35B | 83.93B | 15.50B | 15.03B | 6.30 |
|
UL
Unilever Plc Adr
|
59.33 | 145.17B | 65.10B | 6.16B | 0 | 2.4569 |
|
CL
Colgate Palmolive Co
|
86.86 | 70.08B | 19.95B | 2.90B | 3.47B | 3.54 |
|
KVUE
Kenvue Inc
|
22.17 | 42.93B | 15.30B | 1.06B | 1.45B | 0.55 |
|
KMB
Kimberly Clark Corp
|
127.93 | 42.09B | 19.75B | 2.47B | 2.39B | 7.34 |
Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-23-25 | Downgrade | Needham | Buy → Hold |
| Jun-04-25 | Reiterated | Needham | Buy |
| Apr-29-25 | Downgrade | TD Cowen | Buy → Hold |
| Feb-18-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-10-25 | Downgrade | Citigroup | Neutral → Sell |
| Jan-07-25 | Initiated | BTIG Research | Buy |
| Dec-17-24 | Initiated | Morgan Stanley | Overweight |
| Nov-14-24 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-22-24 | Initiated | Needham | Buy |
| Aug-09-24 | Downgrade | Imperial Capital | Outperform → In-line |
| May-22-24 | Downgrade | Citigroup | Buy → Neutral |
| Apr-16-24 | Downgrade | Jefferies | Buy → Hold |
| Apr-10-24 | Initiated | Canaccord Genuity | Buy |
| Feb-28-24 | Upgrade | Imperial Capital | In-line → Outperform |
| Feb-26-24 | Initiated | Leerink Partners | Market Perform |
| Dec-07-23 | Initiated | Imperial Capital | In-line |
| Jul-28-23 | Initiated | TD Cowen | Outperform |
| Apr-11-23 | Initiated | Robert W. Baird | Neutral |
| Feb-09-23 | Upgrade | Jefferies | Hold → Buy |
| Nov-08-22 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-08-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Oct-17-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-07-22 | Initiated | Truist | Hold |
| Jul-15-22 | Initiated | SVB Leerink | Underperform |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Apr-01-22 | Resumed | Credit Suisse | Outperform |
| Mar-10-22 | Initiated | Deutsche Bank | Hold |
| Dec-02-21 | Initiated | Jefferies | Hold |
| Nov-11-21 | Upgrade | Piper Sandler | Neutral → Overweight |
| Jul-06-21 | Initiated | BofA Securities | Neutral |
| May-20-21 | Upgrade | Credit Suisse | Neutral → Outperform |
| Apr-21-21 | Initiated | Truist | Hold |
| Mar-09-21 | Initiated | Credit Suisse | Neutral |
| Mar-02-21 | Upgrade | Citigroup | Neutral → Buy |
| Feb-17-21 | Initiated | Citigroup | Neutral |
| Feb-12-21 | Initiated | Piper Sandler | Neutral |
| Feb-08-21 | Initiated | Tigress Financial | Buy |
View All
Hims Hers Health Inc Stock (HIMS) Latest News
Soleil Boughton, Hims & Hers health CLO, sells $150k in stock - Investing.com Australia
Deadline Alert: Hims & Hers Health, Inc. (HIMS) Investors - GlobeNewswire
Hims & Hers stock pares losses on data despite Novo Nordisk litigation fears By Investing.com - Investing.com South Africa
Hims & Hers stock pares losses on data despite Novo Nordisk litigation fears - Investing.com
Deadline Alert: Hims & Hers Health, Inc. (HIMS) Investors Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - GlobeNewswire Inc.
Hims & Hers reports 10.3% weight loss in customers using GLP-1 treatments - Investing.com Canada
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Hims & Hers Health - WV News
Novo Nordisk Implodes After Wegovy Warning—Is The Weight-Loss Bubble Bursting? - Benzinga
Hims & Hers Data Shows Personalized GLP-1 Plans Drive Real Weight Loss, Few Side Effects, and Strong Adherence to Care - Hims
Personalized GLP-1 plans drive real weight loss, few side effects, and strong adherence to care - Hims & Hers Newsroom
Levi & Korsinsky Reminds Hims & Hers Health, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 25, 2025HIMS - Morningstar
Hims & Hers Health: Hold Rating Amid Slowing Growth and Uncertain Prospects - TipRanks
Top Medical Stocks To Watch Today – July 27th - Defense World
Hims & Hers Health, Inc. (NYSE:HIMS) Receives Consensus Recommendation of “Reduce” from Brokerages - Defense World
Hims & Hers Health (HIMS) Expands into Canada with a New Weight Loss Program - Insider Monkey
Class Action Lawsuit Filed: Hims & Hers Health, Inc. (HIMS)Join by August 25, 2025Contact Levi & Korsinsky - ACCESS Newswire
Hims & Hers Health (HIMS): Is This High-Growth Telehealth Stock Justified at a 69x P/E? - AInvest
HIMS and SRPT ALERTS: Bragar Eagel & Squire, P.C. Reminds - GlobeNewswire
Hims & Hers Health, Inc. (HIMS) Outperforms Broader Market: What You Need to Know - Yahoo Finance
Hims & Hers Health, Inc.: Please contact the Portnoy Law - GlobeNewswire
HIMS ANNOUNCEMENT: Kessler Topaz Meltzer & Check, LLP - GlobeNewswire
Did You Lose Money on Hims & Hers Health, Inc. (HIMS)? Levi & Korsinsky Urges Investors to Act Before August 25, 2025 - ACCESS Newswire
HIMS vs. TDOC: Which Direct-to-Consumer Health Stock Wins Now? - Nasdaq
Levi & Korsinsky Notifies Hims & Hers Health, Inc. (HIMS) InvestorsLead Plaintiff Deadline on August 25, 2025 - ACCESS Newswire
Class Action Alert: Levi & Korsinsky Reminds Hims & Hers Health, Inc. (HIMS) Investors of August 25, 2025 Deadline - ACCESS Newswire
Hims & Hers: Strategic Expansion and Innovation Fuel Investor Optimism as Q2 Earnings Loom - AInvest
Hims & Hers (HIMS) Jumps 14.4% W/W Ahead of Q2 Earnings - MSN
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming Deadlines - GlobeNewswire Inc.
HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit with the Schall Law Firm - PR Newswire
Hims & Hers Health, Inc. (HIMS) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
Hims & Hers Health, Inc. Sued for Securities Law ViolationsInvestors Should Contact The Gross Law Firm Before August 25, 2025 to Discuss Your RightsHIMS - Morningstar
Hims & Hers Health: What's Wall Street Missing In This Weight-Loss Stock? (NYSE:HIMS) - Seeking Alpha
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
Analyzing the Impact of Earnings Reports on Hims & Hers Health Inc Inc. (HIMS) Price Performance - investchronicle.com
Best Healthcare Stocks To Follow Today – July 26th - Defense World
HIMS INVESTOR ALERT: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit - The Malaysian Reserve
Cerity Partners LLC Buys Shares of 11,006 Hims & Hers Health, Inc. (NYSE:HIMS) - Defense World
Hims & Hers Health (NYSE:HIMS) Cut to “Hold” at Wall Street Zen - Defense World
Top Medical Stocks To Watch Now – July 26th - Defense World
Hims & Hers Health (HIMS): Navigating Legal and Regulatory Risks in a Shifting Telehealth Landscape - AInvest
Hims & Hers Health, Inc. Deadline Reminder: Kessler Topaz Meltzer & Check, LLP Reminds HIMS Investors of Important Lead Plaintiff Deadline on August 25, 2025 - WV News
HIMS LOSS ALERT: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Hims & Hers Health, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionHIMS - ACCESS Newswire
GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Hims & Hers - GlobeNewswire
GLOBALLY RECOGNIZED ROSEN LAW FIRM Encourages Hims & Hers Health, Inc. Investors to Secure ... - Bluefield Daily Telegraph
HIMS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Hims & Hers Health, Inc. to Contact the Firm Today! - ACCESS Newswire
Class Action Announcement HIMS: A Securities Fraud Class Action Lawsuit Was Filed Against Hims & Hers Health, Inc. (HIMS) - FinancialContent
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Hims & Hers Health, Inc. of Class Action Lawsuit and Upcoming DeadlinesHIMS - PR Newswire
Cwm LLC Purchases 2,633 Shares of Hims & Hers Health, Inc. (NYSE:HIMS) - Defense World
Top Medical Stocks Worth Watching – July 25th - Defense World
HIMS STOCK UPDATE: Hims & Hers Health, Inc. (NYSE:HIMS) is - GlobeNewswire
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Hims & Hers Health, Inc. (HIMS) Investors of August 25, 2025 Deadline - ACCESS Newswire
Hims Hers Health Inc Stock (HIMS) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.16%
1.13%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):